Targeting EBV-positive B- and T/NK-cell lymphomas

Affiliations

Comment

Heather M Long. Blood. 2018.

. 2018 Nov 29;132(22):2315-2316.

doi: 10.1182/blood-2018-10-878587.

No abstract available

Conflict of interest statement

Conflict-of-interest disclosure: The author declares no competing financial interests.

EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation.
McLaughlin LP, Rouce R, Gottschalk S, Torrano V, Carrum G, Wu MF, Hoq F, Grilley B, Marcogliese AM, Hanley PJ, Gee AP, Brenner MK, Rooney CM, Heslop HE, Bollard CM. McLaughlin LP, et al. Blood. 2018 Nov 29;132(22):2351-2361. doi: 10.1182/blood-2018-07-863654. Epub 2018 Sep 27. Blood. 2018. PMID: 30262660 Free PMC article. Clinical Trial.